The young woman who consumed "Magic Honey" and ended up in the ER: "Contains a substance banned for use"

The Ministry of Health has issued a severe and urgent warning to the public against using the weight-loss product "Magic Honey," which is marketed on social media and could be life-threatening. The product, which appears to be a natural and innocent item, actually contains a dangerous chemical substance that has already caused severe health damage among users.

One of the users harmed by the product is A., who was exposed to "Magic Honey" through a friend. In an interview with the program "HaOlam HaBoker" ("The World This Morning"), she described how she purchased it via WhatsApp following promises of rapid weight loss:

"During my conversation with the representative, she sent me a leaflet stating what the product contains. I was told that if I had unusual side effects, it was because it contains caffeine or because I have a sensitivity to plants."

Shortly after starting use, A. experienced a sudden medical deterioration, suffering from headaches, nausea, rapid heartbeat, and hormonal disturbances, which led her to seek treatment at an emergency room.

"I started feeling hot flashes coming out of my whole body. I was dizzy and about to faint," she described the moments of distress.

In the hospital, medical staff were initially unable to identify the cause of her condition, providing only basic pain relief. The incident also caused hormonal disturbances that left A. with deep anxiety. She stated that the experience was so shocking that she would no longer trust any weight-loss products, even those approved by the Ministry of Health.

Prof. Eitan Friedman, director of the Institute of Genetics for Early Detection at Assuta, elaborated on the medical aspect:

"'Magic Honey' contains a substance called sibutramine, which has been banned for use in Israel and the Western world since 2010."

The ban was imposed following studies that pointed to a high and lethal risk for severe medical conditions, including strokes, heart attacks, and kidney failure.

At this stage, no response has been received from the company.